Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma.
Behary J, Amorim N, Jiang XT, Raposo A, Gong L, McGovern E, Ibrahim R, Chu F, Stephens C, Jebeili H, Fragomeli V, Koay YC, Jackson M, O'Sullivan J, Weltman M, McCaughan G, El-Omar E, Zekry A. · 2021
Read Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma. by Behary J, Amorim N, Jiang XT, Raposo A, Gong L, McGovern E, Ibrahim R, Chu F, Stephens C, Jebeili H, Fragomeli V, Koay YC, Jackson M, O'Sullivan J, Weltman M, McCaughan G, El-Omar E, Zekry A. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7794332.txt.
Description
Behary and co-authors study how gut microbes shape immune responses in fatty liver disease and liver cancer. The patients had non-alcoholic fatty liver disease with cirrhosis. Some had developed hepatocellular carcinoma, and some had not. The team used metagenomic and metabolomic profiling. They also tested bacterial extracts on immune cells outside the body.
Gut imbalance marked the cirrhosis group. Shifts in microbe makeup and function came with cancer onset. Microbe genes in the cancer group favored short-chain fatty acid output. Metabolite tests confirmed that pattern. Extracts from the cancer group pushed T cells toward a suppressive state. Regulatory T cells grew while CD8+ T cells weakened. Extracts from control groups did not do this.
Catalog record
| CREATOR | Behary J, Amorim N, Jiang XT, Raposo A, Gong L, McGovern E, Ibrahim R, Chu F, Stephens C, Jebeili H, Fragomeli V, Koay YC, Jackson M, O'Sullivan J, Weltman M, McCaughan G, El-Omar E, Zekry A. |
|---|---|
| YEAR | 2021 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 69 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |